Literature DB >> 16402126

The receptor concept: pharmacology's big idea.

H P Rang1.   

Abstract

Chemical signalling is the main mechanism by which biological function is controlled at all levels, from the single cell to the whole organism. Chemical recognition is the function of receptors, which, in addition to recognising endogenous chemical signals, are also the target of many important experimental and therapeutic drugs. Receptors, therefore, lie at the heart of pharmacology. This article describes the way in which the receptor concept originated early in the 20th century, and evolved through a highly innovative stage of quantitative theory based on chemical kinetics, to the point where receptors were first isolated and later cloned, until we now have a virtually complete catalogue of all the receptors present in the genome. Studies on signal transduction are revealing great complexity in the events linking ligand binding to the physiological or therapeutic response. Though some simple quantitative rules of 'receptor theory' are still useful, the current emphasis is on unravelling the pathways that link receptors to responses, and it will be some time before we know enough about them to embark on the next phase of 'receptor theory'.

Mesh:

Substances:

Year:  2006        PMID: 16402126      PMCID: PMC1760743          DOI: 10.1038/sj.bjp.0706457

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

Review 1.  Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.

Authors:  Stephane Angers; Ali Salahpour; Michel Bouvier
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

2.  ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.

Authors:  J MONOD; J WYMAN; J P CHANGEUX
Journal:  J Mol Biol       Date:  1965-05       Impact factor: 5.469

Review 3.  The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology.

Authors:  Rennolds S Ostrom; Paul A Insel
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

4.  The antagonism of acetyl choline by atropine.

Authors:  A J Clark
Journal:  J Physiol       Date:  1926-08-06       Impact factor: 5.182

Review 5.  Drug efficacy at G protein-coupled receptors.

Authors:  Terry Kenakin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

Review 6.  G protein-coupled receptors. II. Mechanism of agonist activation.

Authors:  U Gether; B K Kobilka
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

7.  On the mechanism of desensitization at cholinergic receptors.

Authors:  H P Rang; J M Ritter
Journal:  Mol Pharmacol       Date:  1970-07       Impact factor: 4.436

8.  On the excitability and cooperativity of the electroplax membrane.

Authors:  J P Changeux; T R Podleski
Journal:  Proc Natl Acad Sci U S A       Date:  1968-03       Impact factor: 11.205

9.  An alkylating derivative of benzilylcholine with specific and long-lasting parasympatholytic activity.

Authors:  E W Gill; H P Rang
Journal:  Mol Pharmacol       Date:  1966-07       Impact factor: 4.436

10.  A study of the action of picrotoxin on the inhibitory neuromuscular junction of the crayfish.

Authors:  A Takeuchi; N Takeuchi
Journal:  J Physiol       Date:  1969-11       Impact factor: 5.182

View more
  36 in total

Review 1.  Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays.

Authors:  Steven J Charlton; Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 2.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 3.  Ensemble of G protein-coupled receptor active states.

Authors:  P S-H Park
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

4.  Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice.

Authors:  Abigail E Agoglia; Sarah E Holstein; Vallari R Eastman; Clyde W Hodge
Journal:  Pharmacol Biochem Behav       Date:  2016-01-19       Impact factor: 3.533

5.  Concentration-effect and dose-response relations in clinical pharmacology.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2007-03       Impact factor: 4.335

6.  Using the self-administration of apomorphine and cocaine to measure the pharmacodynamic potencies and pharmacokinetics of competitive dopamine receptor antagonists.

Authors:  Andrew B Norman; Michael R Tabet; Mantana K Norman; Vladimir L Tsibulsky
Journal:  J Neurosci Methods       Date:  2010-10-23       Impact factor: 2.390

7.  A receptor theory-based semimechanistic PD model for the CCR5 noncompetitive antagonist maraviroc.

Authors:  Philippe Jacqmin; Lynn McFadyen; Janet R Wade
Journal:  Br J Clin Pharmacol       Date:  2008-04       Impact factor: 4.335

Review 8.  Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors.

Authors:  P G Strange
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

9.  What systems can and can't do.

Authors:  T Kenakin
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

10.  A study of antagonist affinities for the human histamine H2 receptor.

Authors:  J G Baker
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.